期刊文献+

^(131)I治疗儿童和青少年Graves病的研究进展 被引量:2

Research Development of ^(131)I Treatment for Graves Disease in Adolescents and Children
下载PDF
导出
摘要 Graves病是儿童和青少年甲状腺功能亢进的最常见病因,是由于遗传倾向、环境因素及免疫调节功能障碍等原因所致的一种综合征,影响儿童和青少年各个系统的发育成熟,特别是骨骼系统和神经系统,其自然缓解率低。目前治疗方法主要包括抗甲状腺药物、131I治疗及手术治疗。近年来,131I治疗在儿童和青少年Graves病的应用日渐广泛。现就131I治疗儿童和青少年Graves病存在的问题和远期安全性予以综述。 Graves disease is a common disease of children and adolescents due to hyperthyroidism,which is a syndrome caused by genetic predisposition,environmental factors and immune dysfunction and others.Graves disease disturbs the development of diverse body systems,especially of skeletal and central nervous systems.Graves disease has a low spontaneous remission.The treatments for Graves disease mainly include antithyroid drugs,^131I therapy and surgery.In recent years,^131I therapy of Graves disease are more widely applied in children and adolescents.Here is to make a review on the existing problems and long-term safety of ^131I treatment for children and adolescents with Graves disease.
出处 《医学综述》 2012年第9期1377-1379,共3页 Medical Recapitulate
关键词 GRAVES病 131I治疗 儿童 青少年 Graves disease ^131I therapy Children Adolescents
  • 相关文献

参考文献20

  • 1Conference Proceeding: Hepatic Toxicity following Treatment for Pediatric Graves' Disease Meeting,October 28,2008. Eunice Ken- nedy Shriver National Institute of Child Health and Human Devel- opment, 2009. [ EB/OL ] http://bpca, nichd, nih. gov/outreach/ index, cfm.
  • 2Hung CS, Chang LY, Sui HH,et al. Clinical and laboratory findings at initial diagnosis in pediatric Graves' disease in Taiwan[ J]. Acta Paediatr Taiwan .2006.47 ( 2 ), 77 -82.
  • 3Gruneiro-papendieck L, Chiesa A, Finkeilstain G, et al. Regarding " Civilini E, Bertoglio L, Melissano G, Chiesa R. Aortic and esopha- geal endografting for secondary aortoentefic fistula. Eur J Vasc En- dovasc Surg 2008 ;36 (3) :297-9"[ J ]. Eur J Vasc Endovasc Surg, 2009,37(5) :620.
  • 4Sato H, Minagawa M, Sasaki N, et al. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcomeE J]. J Pediatr Endocrinol Metab, 2011,24(5/6) :257-263.
  • 5Chiapponi C, Stocker U, Mussack T,et al. The surgical treatment of Graves' disease in children and adolescents [ J ]. World J Surg, 2011,35( 11 ) :2428-2431.
  • 6Zheng W,Jian T,Guizhi Z,et al. Analysis of 1311 therapy and cor- relation factors of Graves' disease patients: a 4-year retrospective study[J]. Nucl Med Commun,2012,33 (1) :97-101.
  • 7Rivkees SA, Cornelius EA. Influence of iodine-131 dose on the outcome of hyperthyroidism in children [ J ]. Pediatrics,2003,111 (4 Pt 1 ) :745-749.
  • 8Bartalena L, Tanda ML. Clinical practice. Graves' ophthalmopathy [J]. N Engl J Med,2009,360(10) :994-1001.
  • 9Gurgul E, Sowinski J. Primary hyperthyroidism-diagnosis and treatment. Indications and contraindications for radioiodine therapy [J], Nucl Med Rev Cent East Eur,2011,14( 1 ) :29-32.
  • 10Bartalena L, Baldeschi L, Dickinson A J, et al. Consensus statement of the European group on Graves' orbitopathy(EUGOGO) on man- agement of Graves' orbitopathy [ J ]. Thyroid,2008,18 ( 3 ) : 333 -346.

二级参考文献22

  • 1赵德善,孔繁振,司宏伟,朱亦堃.儿童和青少年甲状腺功能亢进症的^(131)Ⅰ治疗[J].中华内分泌代谢杂志,2006,22(6):566-568. 被引量:16
  • 2Mettler FA Jr. Direct effects of radiation on specific tissues. In : Gusev IA, et al (eds). Medical management of radiation accidents. 2nd ed. Boca Baton, Fla: CRC Press, 2001,70-116.
  • 3United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) : early effects in man of high doses of radiation. Report to the General Assembly,Annex G, United Nations, Vienna, 1988.
  • 4李国民,李晓兵.人钵辐射损伤病理学.见:邢家骝,王桂林,罗卫东,主编.辐射事故临床医学处理.北京:军事医学科学出版社,2006,131-132.
  • 5Bermon M, Braverman LE, Burke J, et al. MIRD Dose Estimate Report NO. 5. J Nuel Med, 1975,16:857-860.
  • 6ICRP PUBLICATION 53 : Radiation dose to patients from radiopharmaceutieals, 53. Annals of the ICRP, 1987,18:1-4.
  • 7Stabin MG, Stubbs JB, Toohey RE. Radiation dose estimates for radiopharmaceuticals. ORISE Document, April 30,1996, available at www. orise, orau. gov/reacts.
  • 8Hee-Myung Park. The Thyroid Gland, In: Henkin RE, et al ( eds ), Nuclear Medicine, 2nd ed, Philadelphia: Mosby, 2006,790-819.
  • 9中华人民共和国国家职业卫生标准GBZ107-2002放射性性腺疾病诊断标准.见:http://www.nirp.cn.
  • 10Hayek A, Chapman EM, Crowford JD. Long-term results of treatment of thyrotoxlcosis in children and adolescents with radioactive iodine. N Engl J Med. 1970,283:949-953.

共引文献17

同被引文献18

  • 1OKAWA ER, GRANT FD, SMITH JR. Pediatric Graves,disease: decisions regarding therapy [J]. Curr Opin Pediatr,2015,27(4):442-447.
  • 2LEE HS, HWANG JS. The treatment of Gravesr disease inchildren and adolescents [J]. Ann Pediatr Endocrinol Metab,2014,19(3):122-126.
  • 3BAHN RS, BURCH HB, COOPER DS, et al. Hyperthyroidismand other causes of thyrotoxicosis : management guidelines ofthe American Thyroid Association and American Association ofClinical Endocrinologists [J]. Endocr Pract,2011,17(3) :456-520.
  • 4LIU M, JING D, HU J, et al. Predictive factors of outcomesin personalized radioactive iodine ((131 )1) treatment forGraves, disease [J]. Am J Med Sci,2014,48(4) :288-293.
  • 5TRAINO AC, DI MF, LAZZERI M, et al. Study of thecorrelation between administered activity and radiationcommitted dose to the thyroid in 1311 therapy of Graves'disease [J]. Radiat Prot Dosimetry,2001,95(2) : 117-124.
  • 6DI MF, TRAINO AC, BRILL AB, et al. A theoretical modelfor prescription of the patient -specific therapeutic activity forradioiodine therapy of Graves' disease [J]. Phys Med Biol,2002,47(9): 1493-1499.
  • 7NISHIKANT D, CHANDRASEKHAR B, PRAYEEN K, et al.The predictive role of 24h RAIU with respect to the outcome oflow fixed dose radioiodine therapy in patients with diffuse toxicgoiter [J]. Hormones,2012,11(4) :451-457.
  • 8READ CH JR, TANSEY MJ, MENDA Y. A 36 -yearretrospective analysis of the efficacy and safety of radioactiveiodine in treating young Graves' patients [J]. Clin EndoeriolMetab,2004,89(9): 4229-4233.
  • 9邓惠兴,杨爱民,喻铭启,王蕴.利用摄碘率高峰时间推测Graves’甲亢患者有效半减期[J].内分泌外科杂志,2008,2(6):379-381. 被引量:3
  • 10罗章伟,李天资,陆进,方文珠,林敏华.6小时内摄131I率快速推断甲状腺摄碘功能的研究[J].实用医学杂志,2011,27(3):446-448. 被引量:2

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部